Navigation Links
K-V Pharmaceutical Announces Updated Makena® Performance Metrics
Date:11/8/2011

dicare and Medicaid and the possibility; and(e) challenges to our intellectual property rights by actual or potential competitors and challenges to other companies' introduction or potential introduction of generic or competing products by third parties against products sold by the Company;  (7) the possibility that our current estimates of the financial effect of previously announced product recalls could prove to be incorrect;(8) risks related to the Company's highly leveraged capital structure discussed in Part I, Item 2— "Management's Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources" of our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2011, including:(a) the risk that the maturities of our debt obligations may be accelerated due to our inability to comply with covenants and restrictions contained in our loan agreements, including as a result of unanticipated delays in filing restated financial statements and related reports;(b) restrictions on the ability to increase our revenues through certain transactions, including the acquisition or in-licensing of  products; and(c) risks that present or future changes in the Board of Directors may lead to an acceleration of the maturities of the Company's debt;(9) the risks of unexpected delays in our ability to file restated financial statements and related reports;(10) the risk that we may not be able to satisfy the quantitative listing standards of the New York Stock Exchange, including with respect to minimum share price and public float;(11) the possibility that default on one type or class of the Company's indebtedness could result in cross default under, and the acceleration of, its other indebtedness;  and(12) the risks detailed from time to time in the Company's filings with the SEC. This discussion is not exhaustive, but is designed to highlight important factors that may impact our forward-looking statements
'/>"/>
SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. S1P1 Lead Compounds, Assets Generated by Epix Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Target Rationale for S1P1 Agonists Explained.
2. New Video Discusses Dust Collection Equipment for Pharmaceutical Containment
3. Critical Alerts For Barrick Gold, Molycorp, Lockheed Martin, Teva Pharmaceutical, and Tenaris Released By Seven Summits Research
4. Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib at 53rd American Society of Hematology Annual Meeting
5. Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights
6. Planet Biopharmaceuticals, Inc. Divests Assets of Allergy Control Products, Inc.
7. Ancor Acquires WellSpring Pharmaceutical Corporation
8. Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results
9. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
10. Global Pharm Holdings Group, Inc. Completes Acquisition of Qingdao Likang Pharmaceutical Co., Ltd.
11. Vanda Pharmaceuticals Reports Third Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... ZURICH , May 28, 2015  Maetrics ( ... the life sciences sector, wrapped up a successful conference, ... the Medical Technology industry," today in Zurich ... ( http://www.maetrics.ch ) and its Switzerland ... regulation on the Medical Technology field to an exclusive ...
(Date:5/28/2015)... 28, 2015 The controversy surrounding the ... and myomectomies (procedures to remove uterine fibroids) continues, ... is investigating Johnson & Johnson,s Ethicon, Inc. unit, ... devices. According to the report published by The ... the FBI is trying to determine what the ...
(Date:5/28/2015)... 28, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... WebcastWhen: , Thursday, June 4 at 1:00 p.m. ET ... Live on the Internet.  Simply log onto our website ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. Isis is ...
Breaking Medicine Technology:Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3
... 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... March 10, 2011, the company completed its previously ... About Valeant Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ... manufactures and markets a broad range of pharmaceutical ...
... Inc. (Nasdaq: GNVC ) announced financial results for ... the year ended December 31, 2010, the Company reported a ... with a net loss of $18.4 million, or $0.19 per ... the year with $35.2 million in cash, cash equivalents, and ...
Cached Medicine Technology:GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 2GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 3GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 4GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 5GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 6GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 7GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 8
(Date:5/29/2015)... May 29, 2015 Dr. Rodger ... Chronic Fatigue Syndrome is now offering free weekly ... learn about natural ways to reduce symptoms associated ... poor sleep, and brain fog. , To ... and Beating Fibromyalgia call in teleconferences simply go ...
(Date:5/29/2015)... 2015 Javlin continues to fulfill its ... and a larger team, with the intention to better ... share in the U.S. and Canada. , Javlin Inc., ... significant growth in 2014 with its strongest earnings to ... integration platform, CloverETL. To accelerate further progress and ensure ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The ... has transformed the science of the little-known and ... it is co-funding the second FSHD Trial Preparedness ... 2015, at the University of Rochester Medical Center ... 50 stakeholders from around the world, including representatives ...
(Date:5/29/2015)... 2015 Health DataPalooza is a national ... discuss and foster the most effective and innovative ways ... Conference is hosted by the Health Data Consortium, which ... to promote and develop the use of open healthcare ... groups to narrow in on how to actually put ...
(Date:5/29/2015)... An organizational consultant and part-time college ... his memory and may be suffering from early dementia. ... professional life and in his uncertain relationship with his ... career working with corporate and government movers and shakers ... family members around him are being diagnosed with Alzheimer’s, ...
Breaking Medicine News(10 mins):Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 3Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:‘Forgetful’ Professor Struggles With Dementia in Compelling New Novel 2
... INC. (NYSE: RMD ),announced today that on Thursday, ... second quarter of fiscal year 2008, ended December 31,2007. ... p.m. Pacific,Time and will host a conference call to ... The conference call is scheduled to begin at 1:30 ...
... Board,Company (Nasdaq: ABCO ) announced today that it ... Williams, Chairman and Chief Executive,Officer, and Michael T. Kirshbaum, ... the quarter ended December 31, 2007. The,call will be ... Eastern Time.,The Company plans to release its third quarter ...
... QC, Jan. 24 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... into a licensing and,distribution agreement with iNova Pharmaceuticals ... Australia., "Building on the launch of our ... continue to add strong distribution partners as we,prepare ...
... Jan. 24 Align,Technology, Inc. (Nasdaq: ALGN ... method of straightening teeth without wires or brackets, ... and launched a new, interactive web site to ... programs to meet the experience,level of almost every ...
... BRCA mutations would be more willing to test their own ... most U.S. medical groups are opposed, many people support genetic ... breast and/or ovarian cancer later in life, a new study ... Center in Philadelphia, and her colleagues interviewed 53 people ...
... HIV/AIDS Patients in Broward County and,Statewide, Community Open ... Testing, FT. LAUDERDALE, Fla., Jan. 24 AIDS,Healthcare ... ,Out of the,Closet, thrift store and ,AHF Pharmacy, location ... on Saturday, January 26th at 10:00 a.m. This,festive community ...
Cached Medicine News:Health News:RESMED to Webcast Second Quarter 2008 Earnings Conference Call 2Health News:The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008 2Health News:Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova 2Health News:Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova 3Health News:Align Technology Launches Aligntech Institute to Help Invisalign Providers Enhance Treatment Success and Practice Economics 2Health News:Align Technology Launches Aligntech Institute to Help Invisalign Providers Enhance Treatment Success and Practice Economics 3Health News:Next Generation of Parents More Likely to Back Genetic Testing 2Health News:AIDS Healthcare Foundation Hosts Grand Opening of Wilton Manors 'Out of the Closet' & 'AHF Pharmacy' 2Health News:AIDS Healthcare Foundation Hosts Grand Opening of Wilton Manors 'Out of the Closet' & 'AHF Pharmacy' 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: